McCarter Private Wealth Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$691K Buy
28,698
+2,449
+9% +$64.1K 0.24% 93
2026
Q1
$737K Buy
26,249
+4,665
+22% +$124K 0.32% 72
2025
Q4
$537K Buy
21,584
+6,750
+46% +$170K 0.24% 87
2025
Q3
$378K Sell
14,834
-195
-1% -$4.81K 0.19% 96
2025
Q2
$364K Buy
15,029
+700
+5% +$16.3K 0.21% 85
2025
Q1
$363K Buy
14,329
+315
+2% +$8.24K 0.24% 71
2024
Q4
$372K Buy
14,014
+311
+2% +$8.44K 0.24% 72
2024
Q3
$397K Buy
+13,703
New +$400K 0.25% 68

Other funds holding PFE

McCarter Private Wealth Services's PFE Position: Q2 2026 in Review

McCarter Private Wealth Services increased its Pfizer (PFE) stake by 9.3% in Q2 2026, buying an estimated $64.1K and bringing the position to 28,698 shares worth $691K. The position accounts for 0.24% of the portfolio, ranked #93.

McCarter Private Wealth Services first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $737K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • McCarter Private Wealth Services held 28,698 shares of Pfizer worth $691K as of Q2 2026.
  • McCarter Private Wealth Services bought 2,449 Pfizer shares in Q2 2026, an estimated $64.1K.
  • Pfizer made up 0.24% of McCarter Private Wealth Services's portfolio in Q2 2026, its #93 holding.
  • McCarter Private Wealth Services first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • McCarter Private Wealth Services's Pfizer position peaked at $737K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on McCarter Private Wealth Services's 13F filing for Q2 2026, filed 5 Aug 2026.